BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11234877)

  • 1. Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.
    Merrick DT; Gao D; Miller YE; Keith RL; Baron AE; Feser W; Kennedy TC; Blatchford PJ; Braudrick S; Hirsch FR; Heasley L; Bunn PA; Franklin WA
    Cancer Prev Res (Phila); 2016 Jan; 9(1):96-104. PubMed ID: 26542061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas.
    Goto A; Kanda H; Ishikawa Y; Matsumoto S; Kawaguchi N; Machinami R; Kato Y; Kitagawa T
    Jpn J Cancer Res; 1998 May; 89(5):539-47. PubMed ID: 9685858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
    Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
    Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.
    Stead LF; Egan P; Devery A; Conway C; Daly C; Berri S; Wood H; Belvedere O; Papagiannopoulos K; Ryan A; Rabbitts P
    PLoS One; 2013; 8(11):e78823. PubMed ID: 24244370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
    Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
    Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy.
    Gold KA; Wistuba II; Kim ES
    Clin Cancer Res; 2012 Jun; 18(11):3002-7. PubMed ID: 22461458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted molecular characterization of external auditory canal squamous cell carcinomas.
    Basura GJ; Smith JD; Ellsperman S; Bhangale A; Brenner JC
    Laryngoscope Investig Otolaryngol; 2021 Oct; 6(5):1151-1157. PubMed ID: 34667860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation in normal esophagus promotes multiple stages of carcinogenesis but is constrained by clonal competition.
    Murai K; Dentro S; Ong SH; Sood R; Fernandez-Antoran D; Herms A; Kostiou V; Abnizova I; Hall BA; Gerstung M; Jones PH
    Nat Commun; 2022 Oct; 13(1):6206. PubMed ID: 36266286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas.
    Choe JH; Mazambani S; Kim TH; Kim JW
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of lung cancer: clinical implications.
    Larsen JE; Minna JD
    Clin Chest Med; 2011 Dec; 32(4):703-40. PubMed ID: 22054881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity.
    Tan X; Ren S; Fu MZ; Ren S; Yang C; Wu X; Chen T; Latham PS; Meltzer SJ; Fu SW
    Am J Cancer Res; 2021; 11(7):3594-3610. PubMed ID: 34354862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
    Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
    Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 alterations in progenitor lesions of the bronchus, esophagus, oral cavity, and colon.
    Bennett WP
    Cancer Detect Prev; 1995; 19(6):503-11. PubMed ID: 8925519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.